Clinicopathological Features of Lupus Erythematosus Panniculitis (LEP): A Retrospective Analysis of 54 Cases
Open Access
- 25 July 2026
- journal article
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Abstract
Background: Lupus Erythematosus Panniculitis (LEP) is a rare subtype of Cutaneous Lupus Erythematosus. It is a challenging disease to diagnose and treat due to limited understanding of its clinical and histopathological characteristics. Methods: We conducted a retrospective review of 54 biopsy‐proven LEP cases evaluated at a dermatology referral center from 2016 to 2022. Demographic, clinical, laboratory, and treatment data were extracted from medical records, and histopathologic features were reassessed when slides required further characterization. Direct immunofluorescence and serologic results were recorded when available. Statistical analyses were performed using SPSS (v26), with significance defined as p < 0.05. Results: Fifty‐four patients with LEP (female‐to‐male ratio 5:1; mean age 38.8 ± 14.7 years) were included. Coexistent systemic lupus erythematosus (SLE) was present in 24.1% of cases. Delayed diagnosis was significantly associated with lipoatrophy ( p < 0.001). Histopathologic findings most commonly included lymphocytic vasculitis (72.2%), histologic features of discoid lupus erythematosus (68.5%), and lobular panniculitis (63%). ANA, anti‐double‐stranded DNA, and direct immunofluorescence were positive in 24.1%, 16.6%, and 72.2% of patients, respectively. Overall, 85.2% of patients improved clinically. Hydroxychloroquine combined with corticosteroids and mycophenolate mofetil was associated with the highest improvement rates, whereas intralesional corticosteroid therapy appeared least effective, although differences were not statistically significant. Conclusion: It is essential to evaluate the clinical and histopathologic features of patients accurately before diagnosis. Delay in diagnosis may be more common in patients without associated SLE or DLE, although these associations were not statistically significant in our cohort. Hydroxychloroquine‐based combination therapy, particularly with corticosteroids and mycophenolate mofetil, was associated with favorable clinical outcomes, although prospective studies are needed to establish optimal treatment strategies.Keywords
This publication has 24 references indexed in Scilit:
- Disease course, comorbidities, and treatment outcomes of lupus erythematosus panniculitis in adults and children: A retrospective reviewJAAD International, 2026
- Panniculitic primary cutaneous gamma delta T-cell lymphoma with concomitant features of autoimmune disease emphasizing a pathophysiologic continuum of lupus profundus with the panniculitic T cell lymphomasClinics in Dermatology, 2023
- Male sex, discoid lupus erythematosus, and lower limb involvement are associated with systemic lupus in lupus panniculitis patients: A multicenter case series of 74 patientsJournal of the American Academy of Dermatology, 2022
- Clinical Characteristics of Lupus Erythematosus Panniculitis/ProfundusJAMA Dermatology, 2020
- Cutaneous lupus erythematosus: A review of the literatureInternational Journal of Women's Dermatology, 2019
- Paniculitis lúpica: características clínico-patológicas de una serie de 12 pacientesMedicina Clinica, 2018
- Lupus Erythematosus PanniculitisDermatologic Clinics, 2008
- Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T‐cell lymphoma: a spectrum of subcuticular T‐cell lymphoid dyscrasiaJournal of Cutaneous Pathology, 2001
- Panniculitis in Connective Tissue DiseaseArchives of Dermatology, 1983
- The histopathology of lupus erythematosus panniculitisJournal of the American Academy of Dermatology, 1981